Annals of Surgical Oncology, Vol 6, Issue 2 144-149, Copyright © 1999 by Society of Surgical Oncology

ARTICLES

The progression of melanoma nodal metastasis is dependent on tumor thickness of the primary lesion

F. F. Haddad, A. Stall, J. Messina, A. Brobeil, E. Ramnath, L. F. Glass, C. W. Cruse, C. G. Berman and D. S. Reintgen
Department of Surgery, University of South Florida, Tampa, USA.

BACKGROUND: Recent results of several clinical trials using the technique of intraoperative lymphatic mapping and sentinel lymph node (SLN) biopsy confirm the validity of the concept of there being an order to the progression of melanoma nodal metastases. This report reviews the H. Lee Moffitt Cancer Center experience with this procedure, one of the largest series described to date. These data demonstrate that the involvement of the SLNs, as well as higher-echelon nodes, is directly proportional to the melanoma tumor thickness, as measured by the method of Breslow. METHODS: The investigators at the H. Lee Moffitt Cancer Center retrospectively reviewed their experience using lymphatic mapping and SLN biopsies in the treatment of malignant melanoma. All eligible patients with primary malignant melanomas underwent preoperative and intraoperative mapping of the lymphatic drainage of their primary sites, along with SLN biopsies. All patients with positive SLNs underwent complete regional basin nodal dissection. For 20 consecutive patients with one positive SLN, all of the nodes from the complete lymphadenectomy were serially sectioned and examined by S-100 immunohistochemical analysis, to detect additional metastatic disease. RESULTS: Six hundred ninety-three patients consented to undergo lymphatic mapping and SLN biopsy. The SLNs were successfully identified and collected for 688 patients, yielding a 99% success rate. One hundred patients (14.52%) showed evidence of nodal metastasis. The rates of SLN involvement for primary tumors with thicknesses of <0.76 mm, 0.76-1.0 mm, 1.0-1.5 mm, 1.5-4.0 mm, and >4.0 mm were 0%, 5.3%, 8%, 19%, and 29%, respectively. Eighty-one patients underwent complete lymph node dissection after observation of a positive SLN, and only six patients with positive SLNs demonstrated metastatic disease beyond the SLN (7.4%). The tumor thicknesses for these six patients ranged from 2.8 to 6.0 mm. No patient with a tumor thickness of <2.8 mm was found to have evidence of metastatic disease beyond the SLN in complete lymph node dissection. All 20 patients with a positive SLN for whom all of the regional nodes were serially sectioned and examined by S-100 immunohistochemical analysis failed to show additional positive nodes. CONCLUSIONS: These results suggest that regional lymph node involvement may be dependent on the thickness of the primary tumor. As the primary tumor thickness increases, so does the likelihood of involvement of SLNs and higher regional nodes in the basin beyond the positive SLNs.

This article has been cited by other articles:

				J. E. Gershenwald, R. H.I. Andtbacka, V. G. Prieto, M. M. Johnson, A. H. Diwan, J. E. Lee, P. F. Mansfield, J. N. Cormier, C. W. Schacherer, and M. I. Ross Microscopic Tumor Burden in Sentinel Lymph Nodes Predicts Synchronous Nonsentinel Lymph Node Involvement in Patients With Melanoma J. Clin. Oncol., September 10, 2008; 26(26): 4296 - 4303. [Abstract] [Full Text] [PDF]

				F. Niakosari, H. J. Kahn, D. McCready, D. Ghazarian, L. E. Rotstein, A. Marks, A. Kiss, and L. From Lymphatic Invasion Identified by Monoclonal Antibody D2-40, Younger Age, and Ulceration: Predictors of Sentinel Lymph Node Involvement in Primary Cutaneous Melanoma Arch Dermatol, April 1, 2008; 144(4): 462 - 467. [Abstract] [Full Text] [PDF]

				S. L. Wong, M. S. Brady, K. J. Busam, and D. G. Coit Results of Sentinel Lymph Node Biopsy in Patients With Thin Melanoma Ann. Surg. Oncol., March 1, 2006; 13(3): 302 - 309. [Abstract] [Full Text] [PDF]

				R. J. C. L. M. Vuylsteke, P. J. Borgstein, P. A. M. van Leeuwen, H. A. Gietema, B. G. Molenkamp, M. G. S. Muller, P. J. van Diest, J. R. M. van der Sijp, and S. Meijer Sentinel Lymph Node Tumor Load: An Independent Predictor of Additional Lymph Node Involvement and Survival in Melanoma Ann. Surg. Oncol., June 1, 2005; 12(6): 440 - 448. [Abstract] [Full Text] [PDF]

				J. H. Lee, R. Essner, H. Torisu-Itakura, L. Wanek, H. Wang, and D. L. Morton Factors Predictive of Tumor-Positive Nonsentinel Lymph Nodes After Tumor-Positive Sentinel Lymph Node Dissection for Melanoma J. Clin. Oncol., September 15, 2004; 22(18): 3677 - 3684. [Abstract] [Full Text] [PDF]

				J. S. Goydos and D. H. Gorski Vascular Endothelial Growth Factor C mRNA Expression Correlates with Stage of Progression in Patients with Melanoma Clin. Cancer Res., December 1, 2003; 9(16): 5962 - 5967. [Abstract] [Full Text] [PDF]

				R. J. Bleicher, R. Essner, L. J. Foshag, L. A. Wanek, and D. L. Morton Role of Sentinel Lymphadenectomy in Thin Invasive Cutaneous Melanomas J. Clin. Oncol., April 1, 2003; 21(7): 1326 - 1331. [Abstract] [Full Text] [PDF]

				M. E. Reeves, R. Delgado, K. J. Busam, M. S. Brady, and D. G. Coit Prediction of Nonsentinel Lymph Node Status in Melanoma Ann. Surg. Oncol., January 1, 2003; 10(1): 27 - 31. [Abstract] [Full Text] [PDF]

				K. M. McMasters, S. L. Wong, M. J. Edwards, C. Chao, M. I. Ross, R. D. Noyes, V. Viar, P. B. Cerrito, and D. S. Reintgen Frequency of Nonsentinel Lymph Node Metastasis in Melanoma Ann. Surg. Oncol., March 1, 2002; 9(2): 137 - 141. [Abstract] [Full Text] [PDF]

				C. M. Balch, S.-J. Soong, J. E. Gershenwald, J. F. Thompson, D. S. Reintgen, N. Cascinelli, M. Urist, K. M. McMasters, M. I. Ross, J. M. Kirkwood, et al. Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System J. Clin. Oncol., August 15, 2001; 19(16): 3622 - 3634. [Abstract] [Full Text] [PDF]

				Pauline de La Salmonière, J.-J. Grob, B. Dreno, M. Delaunay, and C. Chastang White Blood Cell Count: A Prognostic Factor and Possible Subset Indicator of Optimal Treatment with Low-Dose Adjuvant Interferon in Primary Melanoma Clin. Cancer Res., December 1, 2000; 6(12): 4713 - 4718. [Abstract] [Full Text]

				J. D. Wagner, H.-M. Park, J. J. Coleman III, C. Love, and J. T. Hayes Cervical Sentinel Lymph Node Biopsy for Melanomas of the Head and Neck and Upper Thorax Arch Otolaryngol Head Neck Surg, March 1, 2000; 126(3): 313 - 321. [Abstract] [Full Text] [PDF]